"New - type Weight - loss Drugs: Remarkable Efficacy and Side Effects Coexist"

 

On the path to pursuing health and beauty, weight loss has always been a hot - topic among people. In recent years, new - generation weight - loss therapies have emerged like mushrooms after rain. Among them, semaglutide has drawn much attention.

 

In 2021, semaglutide, a glucagon - like peptide - 1 (GLP - 1) receptor agonist, was approved by the US FDA for long - term weight management in adult patients with obesity or overweight. The clinical trial data is astonishing. For obese patients, using semaglutide once a week can reduce their weight by an average of 15%. Compared with previous weight - loss drugs, its effect is more prominent. Thanks to its profound influence in the field of obesity treatment, GLP - 1 agonists were also named the 2023 Breakthrough of the Year by Science.

 

However, there is a price to pay for this "transformation of beauty". Approximately 60% of users will experience persistent symptoms such as nausea,反胃 (nausea and retching), and vomiting during the medication period, especially when facing food. These distressing side effects have become an important reason for many users to ultimately give up weight - loss.

 

So, how can we make the weight - loss process more "painless"? Developing safer weight - loss drugs without side effects has become a new goal for researchers. It is believed that through continuous exploration and innovation, a more ideal solution will emerge in the field of weight loss, enabling people to pursue health and beauty more easily.